QTTB CIK: 1661998

Q32 Bio Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
192
FY22:
181
FY23:
28.7
FY24:
81.9
FY25:
55.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
19.8
FY22:
47.5
FY23:
18.3
FY24:
10.5
FY25:
6.73
Total assets
Change from FY21 to FY25
millions USD
FY21:
212
FY22:
228
FY23:
47.1
FY24:
92.3
FY25:
61.8

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
17.2
FY22:
22.6
FY23:
14.1
FY24:
16.5
FY25:
11.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
24.8
FY22:
27.9
FY23:
104
FY24:
70.2
FY25:
8.42
(positive)
Change from FY21 to FY25
millions USD
FY21:
170
FY22:
178
FY23:
−183
FY24:
5.68
FY25:
42.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
212
FY22:
228
FY23:
–
FY24:
92.3
FY25:
61.8

All amounts in millions USD Data source:SEC EDGAR